The Trump administration plans to overturn pollution rules that seek to reduce soot emissions from U.S. coal-fired power plants in a move that ...

Gaia posted double-digit year-over-year revenue growth, driven in part by an increase in the streaming video provider’s ...

OnKure's drug candidate pipeline is highlighted by OKI-219, a selective PI3K alpha H1047R inhibitor for the treatment of certain types of breast cancer that began clinical trials in February 2024.

CET The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets The Agfa-Gevaert Group posted strong Q4 revenue growth, profitability and free ...